NASDAQ: PHVS · Life Sciences · 10 alerts · CIK 1830487
Share price
$32.44Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pharvaris N.V. filings on SEC EDGAR ↗
Pharvaris Director Johannes Gerardus Christiaan Petrus Schikan Sells $29K of Stock
Johannes Gerardus Christiaan Petrus Schikan, Director, sold 800 shares of Pharvaris N.V. at $36.19 a share, worth $29K in total on Sep 22, 2026. Shares held after the trade: 115,167 (-0.7%).
Pharvaris CFO / CLO David W. Nassif Sells $219K of Stock
David W. Nassif, CFO / CLO, sold 6,000 shares of Pharvaris N.V. at $36.47 a share, worth $219K in total on Sep 21, 2026. Shares held after the trade: 114,300 (-5.0%).
Peng Lu, President, sold 100,000 shares of Pharvaris N.V. at $35.00 a share, worth $3.5M in total on Sep 17, 2026. Shares held after the trade: 64,953 (-60.6%).
Pharvaris Director Johannes Gerardus Christiaan Petrus Schikan Sells $7M of Stock
Johannes Gerardus Christiaan Petrus Schikan, Director, sold 200,000 shares of Pharvaris N.V. at $35.00 a share, worth $7M in total on Sep 17, 2026. Shares held after the trade: 115,167 (-63.5%).
Pharvaris Director Elisabeth Bjork Sells $1.99M of Stock
Elisabeth Bjork, Director, sold 52,500 shares of Pharvaris N.V. at $37.89 a share, worth $1.99M in total on Sep 17, 2026. Shares held after the trade: 15,167 (-77.6%).
Pharvaris Director Robert Glassman Sells $559K of Stock
Robert Glassman, Director, sold 14,493 shares of Pharvaris N.V. at $38.56 a share, worth $559K in total on Sep 17, 2026. Shares held after the trade: 10,500 (-58.0%).
Pharvaris Chief Early Development Anne Lesage Sells $765K of Stock
Anne Lesage, Chief Early Development, sold 20,000 shares of Pharvaris N.V. at $38.27 a share, worth $765K in total on Sep 17, 2026. Shares held after the trade: 73,969 (-21.3%).